Skip to content
Search

Latest Stories

Tax the super rich in India to raise resources to fight COVID-19, says Nobel laureate

American economist and Nobel laureate Joseph E Stigliz on Monday advocated taxing the super rich class in India to raise resources for fighting the COVID-19 pandemic, if the government fails to pool in the required funds.

He also said the Indian government should not shy away from spending to control the pandemic and help the vulnerable


sections.

"Funds should be targeted at high-impact areas rather than low impact ones, and if you can't get resources, raise taxes as you (India) have a lot of billionaires," Stigliz said at a FICCI-organised interactive session.

There have been recent debates on levying COVID tax on the super rich in India.

On the Centre's call for 'Atmanirbhar Bharat' (Self-reliant India), the noted economist said too much self reliance will lower the standard of living as a lot of products, including vaccines, are imported.

"This gives nativism but is not realistic, as the pandemic and climate change have shown the need for greater collaboration," he said.

Stigliz also said India and the US did not handle the COVID-19 situation well.

Allowing the movement of migrant workers exacerbated the spread of the virus and defeated the purpose of lockdown, he said.

Stigliz criticised the US for widening the divide of racism and income, and "similar divisive politics in India" that will undermine the society and economy.

More For You

Minorities in England face 'lower prescribing rates for diabetes tech'

The disparity is particularly concerning as approximately 5.8 m people across the UK live with diabetes

iStock

Minorities in England face 'lower prescribing rates for diabetes tech'

Highlights

  • Ethnic minorities are less likely to receive continuous glucose monitors despite having higher diabetes rates.
  • People from minority backgrounds make up 17.5 per cent of populations in areas with below-average device prescribing.
  • Ethnicity and deprivation account for up to 77 per cent of variance in diabetes technology prescribing.

People from ethnic minority backgrounds in England have significantly less access to vital diabetes technology, despite being at greater risk of developing the condition, according to groundbreaking research.

The study, published in Diabetic Medicine, reveals that black and south Asian communities face significantly lower prescribing rates for continuous glucose monitors (CGMs) – devices that help people manage their blood glucose levels more effectively than traditional finger-prick tests.

Keep ReadingShow less